Iambic Therapeutics (IAM) Stock: Insider Buying, News & P/E
Net buyingShare price and insider trades
Iambic Therapeutics insider trading at a glance (Oct 20, 2026): in the past 12 months, 1 insider bought $11.5M and 0 sold $0 of IAM stock on the open market.
Setup Odds: how past setups like this did
IAM's latest insider buying (Oct 19, 2026) matched against every similar buy since 2020.
1 insider buying no CEO or CFO
4295 of 9298 past setups like this beat the S&P 500 over the next 90 days (46%).
History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
Get emailed when insiders cluster-buy stocks like IAM
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IAM insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $11.5M | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Iambic Therapeutics, Inc. insider reported open-market purchases totaling $11.5M, while 0 insiders reported sales totaling $0.
IAM stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 19SEC | Evan Lockwood RachlinDirector | Buy | 718,7502,588,248 held (+38%) | $16.00 | $11.5M | +8.3% | — |
Insiders at Iambic Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Evan Lockwood RachlinDirector | $11.5M | — | Oct 19, 2026 | — |
IAM stock: common questions
Are Iambic Therapeutics, Inc. insiders buying IAM stock?
In the past 12 months, 1 insiders reported open-market purchases of IAM worth $11.5M. The latest was Director Evan Lockwood Rachlin bought $11.5M of IAM at $16.00 — first open-market purchase in our records; raises the stake by 38%.
Are Iambic Therapeutics, Inc. insiders selling IAM stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IAM's 52-week range?
Over the past year IAM has traded between $16.34 and $23.81. It last closed at $17.33 on Oct 20, 2026.